SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-09-083147
Filing Date
2009-04-21
Accepted
2009-04-21 10:01:00
Documents
5
Effectiveness Date
2009-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 23522
2 GRAPHIC g34548na_pg001new.jpg GRAPHIC 74983
3 GRAPHIC g34548na_pg002new.jpg GRAPHIC 131754
4 GRAPHIC g34548na_pg003new.jpg GRAPHIC 36078
5 GRAPHIC g34548na_pg004new.jpg GRAPHIC 6990
  Complete submission text file 0001193125-09-083147.txt   369742
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31577 | Film No.: 09760668
SIC: 2834 Pharmaceutical Preparations